NHS to fund world’s largest study into effect of aspirin on cancer
by James Meikle from on (#R7M7)
Potentially 'game-changing' trial will take up to 12 years and monitor 11,000 patients
The world's largest clinical trial to investigate whether taking aspirin every day stops the recurrence of some of the most common cancers is to be funded by Cancer Research UK and the NHS.
About 11,000 patients from more than 100 centres across the UK will be recruited for the study. It will take up to 12 years and involve two groups taking different daily doses of aspirin, either 100mg or 300mg, and one taking dummy, or placebo, tablets.
Continue reading...